Key result
Non-surgical periodontal treatment significantly improved periodontal clinical parameters (p<0.0001) and reduced CRP levels (p<0.02), but did not significantly reduce blood pressure over 180 days.
Why the study?
The study sought to evaluate the effects of non-surgical periodontal treatment on periodontal parameters, systemic blood pressure, and systemic inflammation markers in patients with combined refractory arterial hypertension and stage III grade B periodontitis.
Does non-surgical periodontal treatment reduce blood pressure and systemic inflammation in patients with combined refractory arterial hypertension and stage III grade B periodontitis?
Does non-surgical periodontal treatment reduce blood pressure and systemic inflammation in patients with combined refractory arterial hypertension and stage III grade B periodontitis?
Non-surgical periodontal treatment improves local periodontal parameters and systemic inflammation (CRP) but does not lower blood pressure in patients with refractory arterial hypertension.
NSPT may improve periodontal parameters and BP in RAH with periodontitis; leaves open whether benefits hold in randomized trials.
We sought to evaluate the effects of non-surgical periodontal treatment (NSPT) on periodontal clinical parameters, systemic blood pressure (BP) and plasma levels of systemic inflammation markers in patients with combined refractory arterial hypertension (RAH) and stage III grade B periodontitis. Twenty-seven participants with RAH and periodontitis received NSPT. The analyzed clinical parameters were probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), and plaque index (PI). An assessment was performed for systemic BP, complete blood count, coagulogram, creatinine measurement, C-reactive protein (CRP), glycated hemoglobin, cholesterol, glutamic oxaloacetic transaminase, glutamate pyruvic transaminase, waist-hip ratio, and body mass index. In the follow-up period, twenty-two patients were evaluated at baseline and after 90 and 180 days. The data were submitted to statistical analysis (α=0.05%). As expected, the clinical results showed a significant improvement in the percentages of PI, BOP, PD and CAL, which were statistically significant at 90 and 180 days (p<0.0001). Importantly, NSPT significantly reduced the blood level of CRP (p<0.02). However, no significant reduction in BP parameters was noted in the evaluated follow-up periods. NSPT, despite the benefits in periodontal clinical parameters, reduced the plasma level of CRP but not the BP in patients with combined RAH and periodontitis.
No takes yet. Share an insight, caveat, or question.
Rodrigues et al. (2023) studied Combined refractory arterial hypertension and stage III grade B periodontitis (n=27). Non-surgical periodontal treatment (NSPT) was evaluated on Periodontal clinical parameters, systemic blood pressure, and plasma levels of systemic inflammation markers. Non-surgical periodontal treatment significantly improved periodontal clinical parameters (p<0.0001) and reduced CRP levels (p<0.02), but did not significantly reduce blood pressure over 180 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: